Ascom Holding AG

BATS-CHIXE:ASCNZ Stock Report

Market Cap: CHF 143.7m

Ascom Holding Valuation

Is ASCNZ undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of ASCNZ when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: ASCNZ (CHF3.99) is trading below our estimate of fair value (CHF9.44)

Significantly Below Fair Value: ASCNZ is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for ASCNZ?

Key metric: As ASCNZ is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for ASCNZ. This is calculated by dividing ASCNZ's market cap by their current earnings.
What is ASCNZ's PE Ratio?
PE Ratio9.5x
EarningsCHF 15.20m
Market CapCHF 143.67m

Price to Earnings Ratio vs Peers

How does ASCNZ's PE Ratio compare to its peers?

The above table shows the PE ratio for ASCNZ vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average51.7x
INS Instem
59.8xn/aUK£199.6m
EMIS EMIS Group
40.4x11.0%UK£1.2b
CRW Craneware
83.6x24.3%UK£780.9m
EKF EKF Diagnostics Holdings
22.8xn/aUK£108.9m
ASCNZ Ascom Holding
9.5x11.5%CHF 143.7m

Price-To-Earnings vs Peers: ASCNZ is good value based on its Price-To-Earnings Ratio (9.5x) compared to the peer average (53.2x).

Price to Earnings Ratio vs Industry

How does ASCNZ's PE Ratio compare vs other companies in the European Healthcare Services Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
No. of Companies5PE020406080100+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: ASCNZ is good value based on its Price-To-Earnings Ratio (9.5x) compared to the Global Healthcare Services industry average (32.6x).

Price to Earnings Ratio vs Fair Ratio

What is ASCNZ's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

ASCNZ PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio9.5x
Fair PE Ratio21.4x

Price-To-Earnings vs Fair Ratio: ASCNZ is good value based on its Price-To-Earnings Ratio (9.5x) compared to the estimated Fair Price-To-Earnings Ratio (21.4x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst ASCNZ forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCHF 3.99
CHF 6.65
+66.7%
20.3%CHF 8.00CHF 5.30n/a2
Dec ’25CHF 4.16
CHF 6.65
+60.0%
20.3%CHF 8.00CHF 5.30n/a2
Nov ’25CHF 4.84
CHF 6.65
+37.4%
20.3%CHF 8.00CHF 5.30n/a2
Oct ’25CHF 5.42
CHF 9.67
+78.4%
24.4%CHF 13.00CHF 8.00n/a3
Sep ’25CHF 5.63
CHF 9.67
+71.7%
24.4%CHF 13.00CHF 8.00n/a3
Aug ’25CHF 6.35
CHF 11.17
+75.9%
20.1%CHF 13.00CHF 8.00n/a3
Jul ’25CHF 7.66
CHF 12.17
+58.8%
7.0%CHF 13.00CHF 11.00n/a3
Jun ’25CHF 8.07
CHF 12.17
+50.8%
7.0%CHF 13.00CHF 11.00n/a3
May ’25CHF 7.42
CHF 12.17
+64.0%
7.0%CHF 13.00CHF 11.00n/a3
Apr ’25CHF 8.19
CHF 12.17
+48.6%
7.0%CHF 13.00CHF 11.00n/a3
Mar ’25CHF 7.42
CHF 13.00
+75.3%
10.9%CHF 14.00CHF 11.00n/a3
Feb ’25CHF 7.28
CHF 13.00
+78.6%
10.9%CHF 14.00CHF 11.00n/a3
Jan ’25CHF 8.23
CHF 13.00
+58.0%
10.9%CHF 14.00CHF 11.00n/a3
Dec ’24CHF 10.46
CHF 15.22
+45.5%
2.0%CHF 15.65CHF 15.00CHF 4.163
Nov ’24CHF 9.57
CHF 15.72
+64.2%
3.9%CHF 16.50CHF 15.00CHF 4.843
Oct ’24CHF 10.40
CHF 15.72
+51.1%
3.9%CHF 16.50CHF 15.00CHF 5.423
Sep ’24CHF 10.82
CHF 14.43
+33.4%
13.6%CHF 16.50CHF 11.80CHF 5.633
Aug ’24CHF 11.86
CHF 13.67
+15.2%
22.0%CHF 16.50CHF 9.50CHF 6.353
Jul ’24CHF 10.96
CHF 13.67
+24.7%
22.0%CHF 16.50CHF 9.50CHF 7.663
Jun ’24CHF 9.69
CHF 13.67
+41.0%
22.0%CHF 16.50CHF 9.50CHF 8.073
May ’24CHF 8.64
CHF 13.67
+58.2%
22.0%CHF 16.50CHF 9.50CHF 7.423
Apr ’24CHF 8.11
CHF 12.56
+54.9%
25.7%CHF 16.50CHF 9.25CHF 8.194
Mar ’24CHF 8.75
CHF 12.09
+38.2%
30.7%CHF 16.50CHF 8.10CHF 7.424
Feb ’24CHF 8.15
CHF 12.09
+48.3%
30.7%CHF 16.50CHF 8.10CHF 7.284
Jan ’24CHF 7.42
CHF 12.59
+69.6%
33.1%CHF 17.00CHF 8.10CHF 8.234
Dec ’23CHF 7.91
CHF 13.88
+75.4%
25.5%CHF 17.00CHF 8.10CHF 10.464

Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/19 11:45
End of Day Share Price 2024/12/19 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Ascom Holding AG is covered by 10 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Stefan GächterBaader Helvea Equity Research
Michael StuderBank am Bellevue
Serge RotzerBank Vontobel AG